Quantitative and qualitative congenital deficiency of antithrombin III: A new molecular variant called at III - Barcelona 2
- 1 July 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 51 (1) , 75-81
- https://doi.org/10.1016/0049-3848(88)90284-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").Journal of Clinical Investigation, 1986
- A functional assay of protein C in human plasmaBlood, 1984
- Isolation and characterization of a hereditary abnormal antithrombin III ‘antithrombin III toyama’Thrombosis Research, 1983
- Antithrombin III deficiency: decreased synthesis of a biochemically normal moleculeBlood, 1982
- Human antithrombin III heterogeneityBlood, 1981
- Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1978
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Investigations on Antithrombin III in Normal Plasma and SerumBritish Journal of Haematology, 1975
- Determination of α2-macroglobulin as trypsin-protein esteraseClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966